Donor Leukocyte Infusions (DLIs) in Recurrent Hodgkin Lymphoma (HL) Following Allogeneic Stem Cell Transplantation: Ten-year Experience at the M.D. Anderson Cancer Center

समान संसाधन

• FLUDARABINE-MELPHALAN AS PREPARATIVE REGIMEN FOR REDUCED-INTENSITY ALLOGENEIC STEM CELL TRANSPLANTATION IN RELAPSED AND REFRACTORY HODGKIN’S LYMPHOMA: THE UPDATED M.D. ANDERSON CANCER CENTER EXPERIENCE
  द्वारा: Anderlini, Paolo, और अन्य
  प्रकाशित: (2008)
• AGE OVER 55 YEARS AT DIAGNOSIS INCREASES RISK OF SECOND MALIGNANCIES AFTER AUTO-TRANSPLANTATION FOR HODGKIN’S LYMPHOMA PATIENTS
  द्वारा: Pingali, Sai Ravi, और अन्य
  प्रकाशित: (2017)
• Fludarabine, cyclophosphamide and antithymocyte globulin as total body irradiation-free conditioning for matched related and unrelated allogeneic stem cell transplantation in severe aplastic anemia
  द्वारा: Anderlini, Paolo, और अन्य
  प्रकाशित: (2010)
• Poor hematopoietic stem cell mobilizers: A single institution study of incidence and risk factors in patients with recurrent or relapsed lymphoma
  द्वारा: Hosing, Chitra, और अन्य
  प्रकाशित: (2009)
• Arsenic Trioxide with Ascorbic Acid and High-Dose Melphalan: Results of a Phase II Randomized Trial
  द्वारा: Qazilbash, Muzaffar H., और अन्य
  प्रकाशित: (2008)